British man infected by coronavirus on Japanese cruise ship has died

TOKYO (Reuters) – A British man who was infected by the coronavirus on the Diamond Princess cruise ship in Japan has died, bringing the death toll among people who were aboard the vessel to six, Japan’s government said on Friday.

He was the first foreigner from the ship to die, according to Japan’s Ministry of Health, Labour and Welfare. It did not provide his name or age.

Tennis: Tsitsipas downs Evans to reach Dubai final

DUBAI (AFP) – Stefanos Tsitsipas reached his second final in less than a week on Friday (Feb 28), defeating Dan Evans 6-2, 6-3 at the Dubai Championships.

The Greek, who finished runner-up here a year ago to Roger Federer, won the Marseille trophy last Sunday.

Tsitsipas has now won his last eight matches. Briton Evans was playing the fourth ATP semi-final of his career.

Forty Seven (FTSV) Soars On Reports Of Takeover Interest

Shares of Forty Seven Inc. (FTSV) are up more than 22 percent in pre-market trading on Friday, following reports that Gilead Sciences, Inc. (GILD) is interested in acquiring the clinical-stage, immuno-oncology company.

Forty Seven’s lead investigational asset is Magrolimab (formerly Hu5F9 G4), a humanised monoclonal antibody targeting CD 47, a transmembrane protein overexpressed in many types of cancer.

More info about the Company’s pipeline can be found in our report titled “Forty Seven (FTSV) On A Roll, Up Over 300% In 2 Months.”

FTSV closed Thursday’s trading at $48.79, up 1.01%. In pre-market trading on Friday, the stock is up 21.44% at $59.25.

Stock Alert: Glaukos Drops 29%

Shares of Glaukos Corporation (GKOS), an ophthalmic medical technology company, are sinking more than 29% after the company reported full-year sales outlook, lower than estimates.

For the full-year, Glaukos Corporation sees sales of $290 million to $300 million. The Street estimate stands at $304.73 million.

In the fourth-quarter earnings and revenue, however, beat view.

Net income in the fourth quarter was $36.6 million, or $0.84 per share, compared with $1.8 million, or $0.04 per share, in the year-ago quarter. The positive net income in the fourth quarter was due to an income tax benefit recognized in association with the Avedro acquisition.

Excluding items, loss for the quarter was $2.4 million, or $0.06 per share, compared with income of $3.3 million, or $0.08 per share, in the same quarter a year ago. On an average 8 analysts polled by Thomson Reuters were expecting loss of $0.14 per share.

Net sales rose 22% year-over-year in the fourth quarter to $65.8 million. The consensus estimate was at $62.22 million.

GKOS is currently trading at $43.18, close to its 52-week low of $40.

Cincinnati Bell Amends Merger Deal With Brookfield Infrastructure – Quick Facts

Cincinnati Bell Inc. (CBB) announced Friday that it has amended its definitive merger agreement with Brookfield Infrastructure (BIP, BIP_U.TO) and its institutional partners to increase the consideration payable to holders of outstanding shares of Cincinnati Bell common stock to $12.50 per share in cash from $10.50 per share in cash, which values the transaction at approximately $2.745 billion, including debt.

The revised transaction price represents a 62 percent premium to the closing per share price of $7.72 on December 20, 2019, the last trading day prior to the date when the merger agreement was entered into.

Cincinnati Bell and Brookfield negotiated the amendment following the receipt by Cincinnati Bell on February 27, 2020 of a binding proposal to acquire all outstanding shares of Cincinnati Bell common stock for $12.50 from the infrastructure fund that previously submitted a non-binding proposal on January 22, 2020.

Cincinnati Bell’s Board of Directors approved the amended merger agreement and recommends that Cincinnati Bell’s shareholders vote in favor of adopting the amended Brookfield merger agreement.

The transaction is subject to certain customary closing conditions, including the approval by Cincinnati Bell’s shareholders, expiration or termination of the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 and certain regulatory approvals, and is expected to close by the end of 2020.

Here’s Why Happiness Biotech (HAPP) Investors Are Happy

Shares of Happiness Biotech Group Limited (HAPP) have gained over 13 percent ever since the Company’s official entry into the disinfectant industry on Feb.25, 2020.

Happiness Biotech Group is an innovative China-based nutraceutical and dietary supplements producer focused on the research, development, manufacturing and marketing of a variety of products made from Chinese herbal extracts and other ingredients.

The Fujian Provincial Health Commission has given the Company permission to produce all types of disinfectants, including 75% Alcohol Disinfectant, 84 Disinfectant, and Hand Free Disinfectant, etc. (Fujian is a southeastern Chinese province).

The Company has taken upon itself to produce as much as possible disinfectant products and nutritional products during the epidemic period, and contribute to the prevention and control of the novel coronavirus COVID-19.

Sales for the six months ended September 30, 2019, were $31.36 million, relatively stable compared with $31.43 million in the prior-year period.

Happiness Biotech went public on the Nasdaq Global Select Market on October 25, 2019. The IPO lock-up period expires on April 22, 2020.

HAPP has thus far hit a low of $3.42 and a high of $6.10. In pre-market trading on Friday, the stock is up 8.14% at $5.58.

French fashion Agnes B cancels Paris show due to coronavirus

PARIS (Reuters) – French fashion house Agnes B said on Friday it has canceled its March 2 Paris show due to coronavirus worries.

Some Chinese designers have already canceled shows in Paris Fashion Week.